Transcription of the epstein-barr virus lytic cycle activator BZLF-1 during oxidative stress induction

Biological Trace Element Research

Volumn 137, Issue 1, 2010, Pages 13-22

  Lassoued, Saloua ^a   Gargouri, Bochra ^a   El Feki, Abd El Fatteh ^c   Attia, Hammadi ^a   Van Pelt, Jos ^b  

^a University of Sfax   (Tunisia)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c université de Sfax   (Tunisia)

Author keywords

BZLF 1; Catalase; Epstein Barr virus; Oxidative stress; Superoxide dismutase

Indexed keywords

CATALASE; FERROUS SULFATE; HYDROGEN PEROXIDE; IMMEDIATE EARLY PROTEIN BZLF1; MALONALDEHYDE; SUPEROXIDE DISMUTASE;

ARTICLE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; RAJI CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS REACTIVATION;

CATALASE; CELL LINE, TUMOR; CELL PROLIFERATION; FERROUS COMPOUNDS; HERPESVIRUS 4, HUMAN; HUMANS; HYDROGEN PEROXIDE; MALONDIALDEHYDE; OXIDATIVE STRESS; SUPEROXIDE DISMUTASE; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

HUMAN HERPESVIRUS 4;

EID: 77955514570     PISSN: 01634984     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12011-009-8555-y     Document Type: Article

References (36)

1. G Henle W Henle P Clifford, et al. 1969 Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups J Natl Cancer 43 1147 1157 1:STN:280:DyaE3c%2FjvVCisw%3D%3D
2. Miller G (1990) Epstein-Barr virus. Biology, pathogenesis and medical aspects. In: Fields BN, Knipe DM et al (eds) Virology. Raven Press LTD, New York, pp 1921-1958
3. CJ Ring 1994 The B cell-immortalizing functions of Epstein-Barr virus J Gen Virol 75 1 10.1099/0022-1317-75-1-1 1:CAS:528:DyaK2cXhtlWmtr0%3D 8113717
4. H Wolf C Bogedain F Schwarzmann 1993 Epstein-Barr virus and its interaction with the host Intervirology 35 26 1:CAS:528:DyaK3sXmt1aqsrs%3D 8407248
5. I Joab JC Nicolas G Scwaab, et al. 1991 Detection of anti Epstein Barr virus transactivator, ZEBRA, antibodies in sera from patients with nasopharyngeal carcinoma Int J Cancer 48 647 649 10.1002/ijc.2910480503 1:STN:280:DyaK3MzgtFyhtQ%3D%3D 1649137
6. H Zur Hausen FJ O'Neill UK Freese, et al. 1978 Persisting oncogenic herpesvirus induced by the tumour promoter TPA Nature 272 373 375 10.1038/272373a0 1:CAS:528:DyaE1cXkslWrsbo%3D 204874 (Pubitemid 8308093)
7. A Faggioni C Zompetta S Grimaldi, et al. 1986 Calcium modulation activates Epstein-Barr virus genome in latently infected cells Science 232 1554 1556 10.1126/science.3012779 1:STN:280:DyaL283jsFCmsw%3D%3D 3012779
8. CL Liang JL Chen YP Hsu, et al. 2002 Epstein-Barr virus BZLF1 gene is activated by transforming growth factor-beta through cooperativity of Smads and c-Jun/c-Fos proteins J Biol Chem 277 23345 23357 10.1074/jbc.M107420200 1:CAS:528:DC%2BD38XltF2nsb8%3D 11971895 (Pubitemid 34952165)
9. MG Tovey G Lenoir J Begon-Lours 1978 Activation of latent Epstein-Barr virus by antibody to human IgM Nature 276 270 272 10.1038/276270a0 1:CAS:528:DyaE1MXitVajtbY%3D 213727
10. F Cerimele T Battle R Lynch, et al. 2005 Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr virus (EBV)-positive versus EBV-negative Burkitt's lymphpoma Proc Natl Acad Sci 102 175 179 10.1073/pnas.0408381102 1:CAS:528:DC%2BD2MXmtlensg%3D%3D 15611471 (Pubitemid 40094448)
11. B Gargouri S Saloua Lassoued W Ayadi, et al. 2009 Lipid peroxidation and antioxidant system in the tumor and in the blood of patients with nasopharyngeal carcinoma Biol Trace Elem Res 10.1007/s12011-009-8384-z.b
12. BN Ames 1983 Dietary carcinogens and anticarcinogens. Oxygen radicals and degenerative disease Science 221 1256 1264 10.1126/science.6351251 1:CAS:528:DyaL3sXlsFKqsr8%3D 6351251
13. JM Mates C Perez-Gomez IN De Castro 1999 Antioxidant enzymes and human diseases Clin Biochem 32 595 603 10.1016/S0009-9120(99)00075-2 1:CAS:528:DC%2BD3cXos12jsQ%3D%3D 10638941 (Pubitemid 30039087)
14. S Lassoued R Ben Ameur W Ayadi, et al. 2008 Epstein-Barr virus induces an oxidative stress during the early stages of infection in B lymphocytes, epithelial, and lymphoblastoid cell lines Mol Cell Biochem 313 179 186 10.1007/s11010-008-9755-z 1:CAS:528:DC%2BD1cXmtlSru7g%3D 18414998
15. B Gargouri J Van Pelt A El feki, et al. 2009 Induction of Epstein Barr Virus (EBV) lytic cycle in vitro causes oxidative stress in lymphoblastoïde B cell lines Mol Cell Biochem 324 55 63 10.1007/s11010-008-9984-1 1:CAS:528:DC%2BD1MXitlansrc%3D 19082543
16. B Gruhne R Sompallae D Marescotti, et al. 2009 The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of oxygen species Proc Natl Acad Sci USA 106 2313 2318 10.1073/pnas.0810619106 1:CAS:528:DC%2BD1MXit1yks7s%3D 19139406
17. RJV Pulvertaft 1965 Cytology of Burkitt's tumor (African lymphoma) Lancet 1 238
18. Rickinson AB, Kieff E (1996) Eptein-Barr virus. In: Fields BN, Knipe DM, Howley PM (eds) Fields virology. Lippincot-Raven Publishers, Philadelphia, pp 2397-244618
19. M Biggin M Bodescot M Perricaudet, et al. 1987 Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells J Virol 61 3120 3132 1:STN:280:DyaL2szhtFyksQ%3D%3D 3041034
20. JM Braughler LA Duncan RL Chase 1986 The involvement of iron in lipid peroxidation. Importance of ferric to ferrous ratios in initiation J Biol Chem 261 10282 10289 1:CAS:528:DyaL28XltFSmu78%3D 3015924
21. P Moore R Boshoff Y Weiss, et al. 1996 Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV Science 274 1739 1744 10.1126/science.274.5293.1739 1:CAS:528:DyaK28Xntlyqtbg%3D 8939871 (Pubitemid 26414912)
22. GK Hong ML Gulley, et al. 2005 Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model J Virol 79 13993 14003 10.1128/JVI.79.22.13993-14003.2005 1:CAS:528:DC%2BD2MXht1ShsLrP 16254335 (Pubitemid 41552698)
23. H Niller H Wolf J Minarovits 2008 Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases Autoimmunity 41 298 328 10.1080/08916930802024772 1:CAS:528: DC%2BD1cXltFCmu7o%3D 18432410 (Pubitemid 351593860)
24. WH Feng B Israel N Raab-Traub, et al. 2002 Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors Cancer Res 62 1920 1926 1:CAS:528:DC%2BD38XisVSitLg%3D 11912175
25. EM Westphal W Blackstock W Feng, et al. 2000 Activation of lytic Epstein-Barr virus (EBV) infection by radiation and sodium butyrate in vitro and in vivo: a potential method for treating EBV-positive malignancies Cancer Res 60 5781 5788 1:CAS:528:DC%2BD3cXnvVSntrc%3D 11059774
26. Ju-Hong Jiang N Wang A Li, et al. 2006 Hypoxia can contribute to the induction of the Epstein-Barr virus (EBV) lytic cycle J Clin Virol 37 98 103 10.1016/j.jcv.2006.06.013 1:CAS:528:DC%2BD28XhtVajsLrK 16931136 (Pubitemid 44441974)
27. C Swanton N Jones 2001 Strategies in subversion: de-regulation of the mammalian cell cycle by viral gene products Int J Exp Pathol 82 3 13 10.1046/j.1365-2613.2001.00165.x 1:CAS:528:DC%2BD3MXltFaqsbs%3D 11422537 (Pubitemid 32578833)
28. Da-Jiang Li Mu-Sheng Zeng Jian-ming Wen, et al. 1991 Participation of p53 protein in the cellular response to DNA damage Cancer res 23 6304 6311
29. RB Tishler SK Calderwood CN Coleman, et al. 1993 Increases in sequence specific DNA binding by p53 following treatment with chemotherapeutic and DNA damaging agents Cancer Res 53 2212 2216 1:CAS:528:DyaK3sXks1amurk%3D 8485705
30. RA Woo KG Mc Lure SP Lees Miller, et al. 1998 DNA dependant protein kinase acts upstream of P53 in reponse to DNA damage Nature 394 700 704 10.1038/29343 1:CAS:528:DyaK1cXlsFKls7g%3D 9716137 (Pubitemid 28389800)
31. MT Osborn 1996 Chambers TC Role of the stress-activated/c-Jun NH2-terminal protein kinase pathway in the cellular response to adriamycin and other chemotherapeutic drugs J Biol Chem 48 30950 30955
32. S Basu KR Rozenswei M Youmell, et al. 1998 The DNA dependant protein kinase participates in the activation of NF kB following DNA damage Biochem Biophys Res Commun 247 79 83 10.1006/bbrc.1998.8741 1:CAS:528:DyaK1cXjvVSit74%3D 9636658 (Pubitemid 28412529)
33. AL Cheng SE Chuang GM Lai, et al. 1998 Universal activation of NF kB by anticancer drugs in cancer cell lines Proc Am Assoc Cancer Res 39 1465 Abstract
34. PJ Farell DT Rowe MC Rooney, et al. 1989 Epstein-Barr virus BZLF1 trans-activator specifically binds to a consensus AP1 sites and is related to c-fos EMBO J 8 127 132
35. W Hammerschmidt B Sugden 1988 Identification and characterization of oriLyt, a lytic origin of DNA replication of Epstein-Barr virus Cell 3 427 433 10.1016/0092-8674(88)90028-1 (Pubitemid 18261432)
36. G Packham A Economou CM Rooney 1990 Structure and function of the Epstein-Barr virus BZLF1 protein J Virol 5 2110 2116